Back to Results
First PageMeta Content
Brain / Hydantoins / Phenytoin / Teratogens / Fosphenytoin / Purple glove syndrome / Status epilepticus / Pfizer / Lorazepam / Medicine / Epilepsy / Anticonvulsants


U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived
Add to Reading List

Open Document

File Size: 342,06 KB

Share Result on Facebook

Company

Pfizer / Worldwide Safety Strategy Pfizer Inc / /

Country

United States / /

Event

FDA Phase / /

MedicalCondition

Purple Glove Syndrome / status epilepticus / seizures / /

MedicalTreatment

neurosurgery / /

Organization

Intravenous Administration of Phenytoin and Fosphenytoin / U.S. Food and Drug Administration / /

Position

Vice President / /

Product

fosphenytoin sodium / phenytoin sodium / Phenytoin / Dilantin / Cerebyx / US / /

Technology

neurosurgery / /

SocialTag